$4.165
-0.136 (-3.27%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GLMD por análisis de gráficos similares
Alphio's GLMD stock price prediction model matches the current Galmed Pharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.04 (-3.11%). The 1-week path is $4.46 (+7.08%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Galmed Pharmaceuticals Ltd?
Galmed Pharmaceuticals Ltd (GLMD) is not a good buy right now due to its declining financial performance and negative market sentiment. The current price is $4.17, and the stock has experienced a year-to-date change of -36.73%. Additionally, the RSI is at 39.53, indicating that the stock is nearing oversold territory but has not yet shown signs of recovery. The main risk is the negative net income, which was -4,818,000 USD in Q4 2025, reflecting ongoing financial struggles.
GLMD cerró en $4.17 el Friday, tras bajar -3.27%
Galmed Pharmaceuticals Ltd (GLMD) last closed at $4.165, losing -3.27%. These facts feed the 1-day and 1-week GLMD price prediction above.
Consenso de analistas
Galmed Pharmaceuticals Ltd (GLMD): 5 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Galmed Pharmaceuticals Ltd (GLMD) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GLMD, ordenadas por similitud.
Análisis de estacionalidad de GLMD
Historically the probability of a positive August return for GLMD is 0.00%. January offers the highest probability of a positive month at 26.23%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de GLMD
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $1.68 | $1.82 | $2.08 | -56.29% |
| Sep 2026 | $1.49 | $1.63 | $1.77 | -60.75% |
| Oct 2026 | $1.91 | $1.99 | $2.19 | -52.30% |
| Nov 2026 | $2.02 | $2.21 | $2.36 | -46.95% |
| Dec 2026 | $2.00 | $2.21 | $2.24 | -46.95% |
En 2026, se proyecta que Galmed Pharmaceuticals Ltd (GLMD) oscile entre $1.49 y $2.36.
Previsión mensual de Galmed Pharmaceuticals Ltd para 2026
En Aug de 2026, se proyecta que Galmed Pharmaceuticals Ltd promedie $1.82, con un mínimo de $1.68 y un máximo de $2.08.
En Sep de 2026, se proyecta que Galmed Pharmaceuticals Ltd promedie $1.63, con un mínimo de $1.49 y un máximo de $1.77.
En Oct de 2026, se proyecta que Galmed Pharmaceuticals Ltd promedie $1.99, con un mínimo de $1.91 y un máximo de $2.19.
En Nov de 2026, se proyecta que Galmed Pharmaceuticals Ltd promedie $2.21, con un mínimo de $2.02 y un máximo de $2.36.
En Dec de 2026, se proyecta que Galmed Pharmaceuticals Ltd promedie $2.21, con un mínimo de $2.00 y un máximo de $2.24.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.